1.Nakamura S,. Impact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis. Gut 2002;51:490-5. 2.Nakamura S. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer 2003;97:2462-73. 3.Nakamura S. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Cancer 2005;104:532-40. 4.Nakamura S. Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation. Gut 2007;56:1358-63. 5.Yanai S. Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients. Cancer 2011;117:2467-77. 6.Nakamura S. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut 2012;61:507-13. 7.Nakamura S. Gastrointestinal lymphoma: recent advances in diagnosis and treatment. Digestion 2013;87:182-8. 8.Maehata Y. Characteristics of primary and metachronous gastric cancers discovered after Helicobacter pylori eradication: A multicenter propensity score-matched study. Gut Liver 2017;11:628-34. (1208 words, excluding spaces; Nakamura S)